Roche Faces First Trial of Claims Over Raptiva Psoriasis Drug Infections - Bloomberg

Roche Faces archetypal Trial of Claims concluded Raptiva Psoriasis Drug Infections Bloomberg Roche Holding Ag (ROG)'s Genentech Inc. is facing the first legal proceeding of patients' claims that its withdrawn Raptiva disease of the skin drug spawned fatal infections in some users. Officials of Genentech, a definite quantity of Basel, Switzerland-based drugmaker Roche, ... Link To Article